Vitrocap N for floaters – 90 capsules – 3 month supply – only product specifically for floaters

$89.99

VitroCap®N is a groundbreaking solution for eye floaters:

1. **What Is VitroCap®N?**
– VitroCap®N is a water-soluble nutritional supplement designed to address eye floaters.
– It’s the **first non-invasive and non-surgical** treatment for floaters, making it an exciting breakthrough.

2. **Ingredients:**
– VitroCap®N contains a unique blend of nutrients:
– **Vitamin C**: Supports overall eye health and function.
– **Grapeseed Extract**: Known for its antioxidant properties.
– **Zinc**: Essential for maintaining eye health.
– **L-lysine (Amino Acid)**: Supports vitreous health and function.

3. **Clinical Evidence:**
– A **6-month double-blind, placebo-controlled trial** demonstrated remarkable results:
– **70%** of patients experienced a decrease in floaters.
– Improved **subjective visual disturbances**.
– Reduced **vitreous opacity density**.
– Enhanced **contrast sensitivity**.
– Published in the **ARVO Journal**, this study validates VitroCap®N’s efficacy¹.

4. **Proven Success in Germany:**
– VitroCap®N has been successfully used in Germany for **over a decade**.
– Now, it’s available in Australia, offering hope to those troubled by floaters.

VitroCap®N represents a promising advancement in managing floaters!

Description

VitroCap®N is a groundbreaking solution for eye floaters:

1. **What Is VitroCap®N?**
– VitroCap®N is a water-soluble nutritional supplement designed to address eye floaters.
– It’s the **first non-invasive and non-surgical** treatment for floaters, making it an exciting breakthrough.

2. **Ingredients:**
– VitroCap®N contains a unique blend of nutrients:
– **Vitamin C**: Supports overall eye health and function.
– **Grapeseed Extract**: Known for its antioxidant properties.
– **Zinc**: Essential for maintaining eye health.
– **L-lysine (Amino Acid)**: Supports vitreous health and function.

3. **Clinical Evidence:**
– A **6-month double-blind, placebo-controlled trial** demonstrated remarkable results:
– **70%** of patients experienced a decrease in floaters.
– Improved **subjective visual disturbances**.
– Reduced **vitreous opacity density**.
– Enhanced **contrast sensitivity**.
– Published in the **ARVO Journal**, this study validates VitroCap®N’s efficacy¹.

4. **Proven Success in Germany:**
– VitroCap®N has been successfully used in Germany for **over a decade**.
– Now, it’s available in Australia, offering hope to those troubled by floaters.

VitroCap®N represents a promising advancement in managing floaters!